NCT02123056View on ClinicalTrials.gov

Assessment of Metoprolol in the Prevention of Vasovagal Syncope in Aging Subjects

PHASE4Active, not recruitingINTERVENTIONAL
Enrollment

52

Participants

Timeline

Start Date

October 31, 2014

Primary Completion Date

March 31, 2021

Study Completion Date

December 31, 2025

Conditions
Vasovagal Syncope
Interventions
DRUG

Metoprolol

the daily dose range is 25mg twice a day to a maximum of 100mg twice a day

DRUG

Matching Placebo

the daily dose range is 25mg twice a day to a maximum of 100mg twice a day

Trial Locations (2)

R2H 2A6

St. Boniface General, Winnipeg

H4J 1C5

Hopital du Sacre-Coeur de Montreal, Montreal

All Listed Sponsors
collaborator

Vanderbilt University

OTHER

lead

University of Calgary

OTHER